» Articles » PMID: 16545787

Sphingosine-1-phosphate Effects on Guinea Pig Atrial Myocytes: Alterations in Action Potentials and K+ Currents

Overview
Journal Cardiovasc Res
Date 2006 Mar 21
PMID 16545787
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Sphingosine-1-phosphate (S-1-P), a potent lysophospholipid mediator which is released from platelets during clotting, activates a G-protein-gated inwardly rectifying K+ current (GIRK) in atrial and sino-atrial node myocytes. We denote this current I(K(S-1-P).) A similar GIRK, which is activated by acetylcholine (ACh) and denoted I(K(ACh)), is expressed in atrium. It shortens the action potential duration (APD) and reduces the effective refractory period (ERP). We have examined the effect of S-1-P on APD in guinea pig atrial myocytes by characterizing the rectification properties of I(K(S-1-P)) and evaluating whether I(K(S-1-P)) and I(K(ACh)) exhibit convergence/occlusion.

Methods: Membrane potential and K+ currents were recorded from guinea pig atrial myocytes. Inwardly rectifying K+ currents were recorded using a ramp voltage clamp waveform between +30 to -130 mV from a holding potential of -7 mV. Agonist-induced current changes were obtained by subtracting the control current.

Results: S-1-P (1 and 10 nM) altered both passive and active properties of atrial myocytes. S-1-P increased the threshold current for excitation and decreased the time constant of the subthreshold electrotonic potentials. In addition, both APD50 and APD90 were decreased substantially. Voltage clamp analysis showed that the outward conductance of I(K(IR)) (G(K(IR)out)) was 134.8+/-11.3 pS pF(-1) (n = 19) in S-1-P (100 nM), and 207.0+/-19.6 pS pF(-1) (n = 18) in ACh (10 microM). The ratio of G(K(IR)out):G(K(IR)in) was about 0.7 for both S-1-P and ACh. The EC50 values for the activation of G(K(IR)out) and G(K(IR)in) by S-1-P were 1.6 and 1.3 nM, respectively. Addition of S-1-P (100 nM) after the effect of ACh (10 microM) had developed fully caused very little additional change.

Conclusion: I(K(S-1-P)) is carried by weakly inwardly-rectifying K+ channels that are the same as those activated by ACh. This K+ current can markedly shorten APD in guinea pig atrial myocytes. This effect would be expected to increase the incidence of atrial rhythm disturbances.

Citing Articles

Sphingolipid metabolism and signaling in cardiovascular diseases.

Borodzicz-Jazdzyk S, Jazdzyk P, Lysik W, Cudnoch-Jdrzejewska A, Czarzasta K Front Cardiovasc Med. 2022; 9:915961.

PMID: 36119733 PMC: 9471951. DOI: 10.3389/fcvm.2022.915961.


Molecular Pharmacology and Novel Potential Therapeutic Applications of Fingolimod.

Pournajaf S, Dargahi L, Javan M, Pourgholami M Front Pharmacol. 2022; 13:807639.

PMID: 35250559 PMC: 8889014. DOI: 10.3389/fphar.2022.807639.


Permissive Modulation of Sphingosine-1-Phosphate-Enhanced Intracellular Calcium on BK Channel of Chromaffin Cells.

Wu A, Ohn T, Shei R, Wu H, Chen Y, Lee H Int J Mol Sci. 2021; 22(4).

PMID: 33671654 PMC: 7926978. DOI: 10.3390/ijms22042175.


Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K Current and Intermediate-Conductance Ca-Activated K Channel in Jurkat T-Lymphocytes.

Chang W, Liu P, Wu S Molecules. 2020; 25(19).

PMID: 33023219 PMC: 7582672. DOI: 10.3390/molecules25194525.


Sphingosine 1-phosphate: Lipid signaling in pathology and therapy.

Cartier A, Hla T Science. 2019; 366(6463).

PMID: 31624181 PMC: 7661103. DOI: 10.1126/science.aar5551.